MANUFACTURERS LIFE INSURANCE COMPANY, THE
InsurancePosition in CLDX — Celldex Therapeutics, Inc.
CIK 928047
TORONTO, A6
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,324,266
+$857,339 QoQ
Shares Held
89,338
+14.9% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 252 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $1,655,634,902 across 242 Biotechnology names. CLDX ranks #58 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
554,085 | $275,230,642 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
893,795 | $269,059,108 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,955,733 | $145,662,993 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
539,037 | $129,891,745 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,988,121 | $105,749,602 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
147,961 | $92,259,601 | |
| 7 | RPRX |
Royalty Pharma plc
|
678,768 | $38,058,521 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
441,957 | $36,050,432 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,324,266 | 89,338 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,466,927 | 77,772 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,040,530 | 75,130 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,252,604 | 87,074 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,534,511 | 124,546 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,720,347 | 94,785 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,637,581 | 104,376 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,595,360 | 105,777 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,803,416 | 129,787 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,436,961 | 129,544 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,722,314 | 43,427 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,371,376 | 49,832 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,532,482 | 45,166 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,197,586 | 61,078 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,614,075 | 58,651 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 | $1,530,983 | 54,464 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $1,351,585 | 50,133 | Shares | Defined | 2023-08-11 | |
| 2022-03-31 | $2,163,184 | 63,511 | Shares | Defined | 2023-08-11 | |
| 2021-12-31 | $899,771 | 23,286 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,262,232 | 23,379 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $740,194 | 22,135 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||